Assessing the impact of thrombolysis on progress through inpatient rehabilitation after stroke: a multivariable approach

Background Acute administration of tissue plasminogen activator has been shown to improve immediate and long-term patient recovery after ischaemic stroke. Yet, despite widespread clinical application, many patients who receive acute tissue plasminogen activator still require inpatient rehabilitation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of stroke 2012-08, Vol.7 (6), p.460-464
Hauptverfasser: Meyer, M., Murie-Fernandez, M., Hall, R., Liu, Y., Fang, J., Salter, K., Foley, N., Teasell, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 464
container_issue 6
container_start_page 460
container_title International journal of stroke
container_volume 7
creator Meyer, M.
Murie-Fernandez, M.
Hall, R.
Liu, Y.
Fang, J.
Salter, K.
Foley, N.
Teasell, R.
description Background Acute administration of tissue plasminogen activator has been shown to improve immediate and long-term patient recovery after ischaemic stroke. Yet, despite widespread clinical application, many patients who receive acute tissue plasminogen activator still require inpatient rehabilitation. Aims and Hypothesis This study aimed to examine the effect of tissue plasminogen activator administration on recovery among patients requiring inpatient rehabilitation after stroke in Ontario, Canada. It was hypothesized that after covariate adjustment, administration of tissue plasminogen activator would be associated with accelerated progress through inpatient rehabilitation. Methods Acute and rehabilitation data were retrieved from the Registry of the Canadian Stroke Network and the National Rehabilitation Reporting System for all ischaemic stroke patients admitted to an acute facility and a rehabilitation unit between July 1, 2003 and March 31,2008. Patients were divided into two groups: those who received tissue plasminogen activator and those who were medically eligible but did not receive tissue plasminogen activator. Three rehabilitation progress indicators were compared between groups: Functional Independence Measure gain, active length of stay, and discharge destination. Indicators were modelled using multivariable generalized linear models or logistic regression as appropriate. Results Patients who received tissue plasminogen activator experienced shorter active lengths of stay (log estimate ± standard error: −0.04 ± 0.01 days), and were slightly more likely to be discharged home compared to controls (adjusted odds ratio 1.35, 95% confidence interval 1.004–1.82). No differences were noted on Functional Independence Measure gain during rehabilitation. Conclusion Results suggest that tissue plasminogen activator may contribute to accelerated progress through inpatient rehabilitation; however, there is no evidence to suggest that it contributes to greater functional improvement as measured by the Functional Independence Measure.
doi_str_mv 10.1111/j.1747-4949.2011.00729.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1027041262</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1111_j.1747-4949.2011.00729.x</sage_id><sourcerecordid>1027041262</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4529-eccd68bbcac1fed2e26f3b066bfbec79ad8bef9d75a48e0582119053c133e5ef3</originalsourceid><addsrcrecordid>eNqNkEFv3CAQhVHUKknT_IWKYy92ABvbVL1EUZukilJVbZQjAjzeZWMbF3C7--_Lxumeg4SY0XxvHnoIYUpyms7FJqd1WWelKEXOCKU5ITUT-fYInR4Gbw51QU7QuxA2hJS8LqpjdMIYq8p0T9H2MgQIwY4rHNeA7TApE7HrUufdoF2_CzZgN-LJu5VP5PNgXq2xHScVLYwRe1grbXsbU59I1UXwOETvnuATVniY-2j_KG-V7gGrKW1SZv0eve1UH-D85T1DD1-__Lq6ye6-X99eXd5lpuRMZGBMWzVaG2VoBy0DVnWFJlWlOw2mFqptNHSirbkqGyC8YZQKwgtDiwI4dMUZ-rjsTba_ZwhRDjYY6Hs1gpuDpITVpKSsYgltFtR4F4KHTk7eDsrvEiT3ucuN3Ecq9_HKfe7yOXe5TdIPLy6zHqA9CP8HnYDPC_DX9rB79WJ5--1nKpKcL_KgViA3bvZjCu01_8oWnQ0Rtgdb5Z9kVRc1l4_317IS_McjFfdSFP8AUw20Lg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1027041262</pqid></control><display><type>article</type><title>Assessing the impact of thrombolysis on progress through inpatient rehabilitation after stroke: a multivariable approach</title><source>Access via SAGE</source><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Meyer, M. ; Murie-Fernandez, M. ; Hall, R. ; Liu, Y. ; Fang, J. ; Salter, K. ; Foley, N. ; Teasell, R.</creator><creatorcontrib>Meyer, M. ; Murie-Fernandez, M. ; Hall, R. ; Liu, Y. ; Fang, J. ; Salter, K. ; Foley, N. ; Teasell, R.</creatorcontrib><description>Background Acute administration of tissue plasminogen activator has been shown to improve immediate and long-term patient recovery after ischaemic stroke. Yet, despite widespread clinical application, many patients who receive acute tissue plasminogen activator still require inpatient rehabilitation. Aims and Hypothesis This study aimed to examine the effect of tissue plasminogen activator administration on recovery among patients requiring inpatient rehabilitation after stroke in Ontario, Canada. It was hypothesized that after covariate adjustment, administration of tissue plasminogen activator would be associated with accelerated progress through inpatient rehabilitation. Methods Acute and rehabilitation data were retrieved from the Registry of the Canadian Stroke Network and the National Rehabilitation Reporting System for all ischaemic stroke patients admitted to an acute facility and a rehabilitation unit between July 1, 2003 and March 31,2008. Patients were divided into two groups: those who received tissue plasminogen activator and those who were medically eligible but did not receive tissue plasminogen activator. Three rehabilitation progress indicators were compared between groups: Functional Independence Measure gain, active length of stay, and discharge destination. Indicators were modelled using multivariable generalized linear models or logistic regression as appropriate. Results Patients who received tissue plasminogen activator experienced shorter active lengths of stay (log estimate ± standard error: −0.04 ± 0.01 days), and were slightly more likely to be discharged home compared to controls (adjusted odds ratio 1.35, 95% confidence interval 1.004–1.82). No differences were noted on Functional Independence Measure gain during rehabilitation. Conclusion Results suggest that tissue plasminogen activator may contribute to accelerated progress through inpatient rehabilitation; however, there is no evidence to suggest that it contributes to greater functional improvement as measured by the Functional Independence Measure.</description><identifier>ISSN: 1747-4930</identifier><identifier>EISSN: 1747-4949</identifier><identifier>DOI: 10.1111/j.1747-4949.2011.00729.x</identifier><identifier>PMID: 22264226</identifier><language>eng</language><publisher>London, England: Blackwell Publishing Ltd</publisher><subject>Aged ; Aged, 80 and over ; Analysis of Variance ; Case-Control Studies ; cerebral infarction ; Female ; Fibrinolytic Agents - therapeutic use ; Hospitalization ; Humans ; ischaemic stroke ; Length of Stay ; Male ; Middle Aged ; Ontario ; rehabilitation ; Rehabilitation Centers ; Retrospective Studies ; stroke ; Stroke Rehabilitation ; thrombolysis ; Tissue Plasminogen Activator - therapeutic use ; tPA</subject><ispartof>International journal of stroke, 2012-08, Vol.7 (6), p.460-464</ispartof><rights>2012 The Authors</rights><rights>2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization</rights><rights>2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4529-eccd68bbcac1fed2e26f3b066bfbec79ad8bef9d75a48e0582119053c133e5ef3</citedby><cites>FETCH-LOGICAL-c4529-eccd68bbcac1fed2e26f3b066bfbec79ad8bef9d75a48e0582119053c133e5ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1111/j.1747-4949.2011.00729.x$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1111/j.1747-4949.2011.00729.x$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,1417,21819,27924,27925,43621,43622,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22264226$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meyer, M.</creatorcontrib><creatorcontrib>Murie-Fernandez, M.</creatorcontrib><creatorcontrib>Hall, R.</creatorcontrib><creatorcontrib>Liu, Y.</creatorcontrib><creatorcontrib>Fang, J.</creatorcontrib><creatorcontrib>Salter, K.</creatorcontrib><creatorcontrib>Foley, N.</creatorcontrib><creatorcontrib>Teasell, R.</creatorcontrib><title>Assessing the impact of thrombolysis on progress through inpatient rehabilitation after stroke: a multivariable approach</title><title>International journal of stroke</title><addtitle>Int J Stroke</addtitle><description>Background Acute administration of tissue plasminogen activator has been shown to improve immediate and long-term patient recovery after ischaemic stroke. Yet, despite widespread clinical application, many patients who receive acute tissue plasminogen activator still require inpatient rehabilitation. Aims and Hypothesis This study aimed to examine the effect of tissue plasminogen activator administration on recovery among patients requiring inpatient rehabilitation after stroke in Ontario, Canada. It was hypothesized that after covariate adjustment, administration of tissue plasminogen activator would be associated with accelerated progress through inpatient rehabilitation. Methods Acute and rehabilitation data were retrieved from the Registry of the Canadian Stroke Network and the National Rehabilitation Reporting System for all ischaemic stroke patients admitted to an acute facility and a rehabilitation unit between July 1, 2003 and March 31,2008. Patients were divided into two groups: those who received tissue plasminogen activator and those who were medically eligible but did not receive tissue plasminogen activator. Three rehabilitation progress indicators were compared between groups: Functional Independence Measure gain, active length of stay, and discharge destination. Indicators were modelled using multivariable generalized linear models or logistic regression as appropriate. Results Patients who received tissue plasminogen activator experienced shorter active lengths of stay (log estimate ± standard error: −0.04 ± 0.01 days), and were slightly more likely to be discharged home compared to controls (adjusted odds ratio 1.35, 95% confidence interval 1.004–1.82). No differences were noted on Functional Independence Measure gain during rehabilitation. Conclusion Results suggest that tissue plasminogen activator may contribute to accelerated progress through inpatient rehabilitation; however, there is no evidence to suggest that it contributes to greater functional improvement as measured by the Functional Independence Measure.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis of Variance</subject><subject>Case-Control Studies</subject><subject>cerebral infarction</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>ischaemic stroke</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Ontario</subject><subject>rehabilitation</subject><subject>Rehabilitation Centers</subject><subject>Retrospective Studies</subject><subject>stroke</subject><subject>Stroke Rehabilitation</subject><subject>thrombolysis</subject><subject>Tissue Plasminogen Activator - therapeutic use</subject><subject>tPA</subject><issn>1747-4930</issn><issn>1747-4949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEFv3CAQhVHUKknT_IWKYy92ABvbVL1EUZukilJVbZQjAjzeZWMbF3C7--_Lxumeg4SY0XxvHnoIYUpyms7FJqd1WWelKEXOCKU5ITUT-fYInR4Gbw51QU7QuxA2hJS8LqpjdMIYq8p0T9H2MgQIwY4rHNeA7TApE7HrUufdoF2_CzZgN-LJu5VP5PNgXq2xHScVLYwRe1grbXsbU59I1UXwOETvnuATVniY-2j_KG-V7gGrKW1SZv0eve1UH-D85T1DD1-__Lq6ye6-X99eXd5lpuRMZGBMWzVaG2VoBy0DVnWFJlWlOw2mFqptNHSirbkqGyC8YZQKwgtDiwI4dMUZ-rjsTba_ZwhRDjYY6Hs1gpuDpITVpKSsYgltFtR4F4KHTk7eDsrvEiT3ucuN3Ecq9_HKfe7yOXe5TdIPLy6zHqA9CP8HnYDPC_DX9rB79WJ5--1nKpKcL_KgViA3bvZjCu01_8oWnQ0Rtgdb5Z9kVRc1l4_317IS_McjFfdSFP8AUw20Lg</recordid><startdate>201208</startdate><enddate>201208</enddate><creator>Meyer, M.</creator><creator>Murie-Fernandez, M.</creator><creator>Hall, R.</creator><creator>Liu, Y.</creator><creator>Fang, J.</creator><creator>Salter, K.</creator><creator>Foley, N.</creator><creator>Teasell, R.</creator><general>Blackwell Publishing Ltd</general><general>SAGE Publications</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201208</creationdate><title>Assessing the impact of thrombolysis on progress through inpatient rehabilitation after stroke: a multivariable approach</title><author>Meyer, M. ; Murie-Fernandez, M. ; Hall, R. ; Liu, Y. ; Fang, J. ; Salter, K. ; Foley, N. ; Teasell, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4529-eccd68bbcac1fed2e26f3b066bfbec79ad8bef9d75a48e0582119053c133e5ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis of Variance</topic><topic>Case-Control Studies</topic><topic>cerebral infarction</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>ischaemic stroke</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Ontario</topic><topic>rehabilitation</topic><topic>Rehabilitation Centers</topic><topic>Retrospective Studies</topic><topic>stroke</topic><topic>Stroke Rehabilitation</topic><topic>thrombolysis</topic><topic>Tissue Plasminogen Activator - therapeutic use</topic><topic>tPA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meyer, M.</creatorcontrib><creatorcontrib>Murie-Fernandez, M.</creatorcontrib><creatorcontrib>Hall, R.</creatorcontrib><creatorcontrib>Liu, Y.</creatorcontrib><creatorcontrib>Fang, J.</creatorcontrib><creatorcontrib>Salter, K.</creatorcontrib><creatorcontrib>Foley, N.</creatorcontrib><creatorcontrib>Teasell, R.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of stroke</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meyer, M.</au><au>Murie-Fernandez, M.</au><au>Hall, R.</au><au>Liu, Y.</au><au>Fang, J.</au><au>Salter, K.</au><au>Foley, N.</au><au>Teasell, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing the impact of thrombolysis on progress through inpatient rehabilitation after stroke: a multivariable approach</atitle><jtitle>International journal of stroke</jtitle><addtitle>Int J Stroke</addtitle><date>2012-08</date><risdate>2012</risdate><volume>7</volume><issue>6</issue><spage>460</spage><epage>464</epage><pages>460-464</pages><issn>1747-4930</issn><eissn>1747-4949</eissn><abstract>Background Acute administration of tissue plasminogen activator has been shown to improve immediate and long-term patient recovery after ischaemic stroke. Yet, despite widespread clinical application, many patients who receive acute tissue plasminogen activator still require inpatient rehabilitation. Aims and Hypothesis This study aimed to examine the effect of tissue plasminogen activator administration on recovery among patients requiring inpatient rehabilitation after stroke in Ontario, Canada. It was hypothesized that after covariate adjustment, administration of tissue plasminogen activator would be associated with accelerated progress through inpatient rehabilitation. Methods Acute and rehabilitation data were retrieved from the Registry of the Canadian Stroke Network and the National Rehabilitation Reporting System for all ischaemic stroke patients admitted to an acute facility and a rehabilitation unit between July 1, 2003 and March 31,2008. Patients were divided into two groups: those who received tissue plasminogen activator and those who were medically eligible but did not receive tissue plasminogen activator. Three rehabilitation progress indicators were compared between groups: Functional Independence Measure gain, active length of stay, and discharge destination. Indicators were modelled using multivariable generalized linear models or logistic regression as appropriate. Results Patients who received tissue plasminogen activator experienced shorter active lengths of stay (log estimate ± standard error: −0.04 ± 0.01 days), and were slightly more likely to be discharged home compared to controls (adjusted odds ratio 1.35, 95% confidence interval 1.004–1.82). No differences were noted on Functional Independence Measure gain during rehabilitation. Conclusion Results suggest that tissue plasminogen activator may contribute to accelerated progress through inpatient rehabilitation; however, there is no evidence to suggest that it contributes to greater functional improvement as measured by the Functional Independence Measure.</abstract><cop>London, England</cop><pub>Blackwell Publishing Ltd</pub><pmid>22264226</pmid><doi>10.1111/j.1747-4949.2011.00729.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1747-4930
ispartof International journal of stroke, 2012-08, Vol.7 (6), p.460-464
issn 1747-4930
1747-4949
language eng
recordid cdi_proquest_miscellaneous_1027041262
source Access via SAGE; MEDLINE; Access via Wiley Online Library
subjects Aged
Aged, 80 and over
Analysis of Variance
Case-Control Studies
cerebral infarction
Female
Fibrinolytic Agents - therapeutic use
Hospitalization
Humans
ischaemic stroke
Length of Stay
Male
Middle Aged
Ontario
rehabilitation
Rehabilitation Centers
Retrospective Studies
stroke
Stroke Rehabilitation
thrombolysis
Tissue Plasminogen Activator - therapeutic use
tPA
title Assessing the impact of thrombolysis on progress through inpatient rehabilitation after stroke: a multivariable approach
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T19%3A45%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20the%20impact%20of%20thrombolysis%20on%20progress%20through%20inpatient%20rehabilitation%20after%20stroke:%20a%20multivariable%20approach&rft.jtitle=International%20journal%20of%20stroke&rft.au=Meyer,%20M.&rft.date=2012-08&rft.volume=7&rft.issue=6&rft.spage=460&rft.epage=464&rft.pages=460-464&rft.issn=1747-4930&rft.eissn=1747-4949&rft_id=info:doi/10.1111/j.1747-4949.2011.00729.x&rft_dat=%3Cproquest_cross%3E1027041262%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1027041262&rft_id=info:pmid/22264226&rft_sage_id=10.1111_j.1747-4949.2011.00729.x&rfr_iscdi=true